/PRNewswire/ Signifying a monumental step forward in the domain of powered antibody therapies, SparX is thrilled to announce that the first patient has been.
SparX Group Announces First Patient Dosed with SPX-303 Injection, the First in Its Class of anti-LILRB2/PD-L1 Bispecific Antibody Drugs streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Spearheading the field of powered antibody therapies, SparX Biopharmaceutical Corp. proudly announces the addition of Dr. Roland Meier as their.
/PRNewswire/ With a mission of "Bolstering human immunity by utilizing empowered antibody therapies", the SparX Group is rapidly becoming a significant.
/PRNewswire/ The SparX Group of Cayman Island recently announced the closing of a B-round fund-raising of over 30 million USD. Co-founded by Dr. Gui-Dong.